Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct 7;2009(4):CD006379.
doi: 10.1002/14651858.CD006379.pub3.

Benzodiazepines for delirium

Edmund Lonergan  1 , Jay Luxenberg, Almudena Areosa Sastre
Affiliations

Benzodiazepines for delirium

Edmund Lonergan et al. Cochrane Database Syst Rev. .

Abstract

Background: Delirium occurs in 30% of hospitalised patients and is associated with prolonged hospital stay and increased morbidity and mortality. The results of uncontrolled studies have been unclear, with some suggesting that benzodiazepines may be useful in controlling non-alcohol related delirium.

Objectives: To determine the effectiveness and incidence of adverse effects of benzodiazapines in the treatment of non-alcohol withdrawal related delirium.

Search strategy: The trials were identified from a search of the Specialized Register of the Cochrane Dementia and Cognitive Improvement Group on 26 February 2008 using the search terms: (deliri* or confusion) and (benzo* or lorazepam," or "alprazolam" or "ativan" or diazepam or valium or chlordiazepam).The CDCIG Specialized Register contains records from major health databases (including MEDLINE, EMBASE, CINAHL, PsycINFO, CENTRAL, LILACS) as well as many ongoing trial databases and grey literature sources.

Selection criteria: Trials had to be unconfounded, randomized and with concealed allocation of subjects. Additionally, selected trials had to have assessed patients pre- and post-treatment. Where crossover design was present, only data from the first part of the trial were to be examined.

Data collection and analysis: Two reviewers extracted data from included trials. Data were pooled where possible, and were to be analysed using appropriate statistical methods. Odd ratios or average differences were to be calculated. Only "intention to treat" data were to be included.

Main results: Only one trial satisfying the selection criteria could be identified. In this trial, comparing the effect of the benzodiazepine, lorazepam, with dexmedetomidine, a selective alpha-2-adrenergic receptor agonist, on delirium among mechanically ventilated intensive care unit patients, dexmedetomidine treatment was associated with an increased number of delirium- and coma-free days compared with lorazepam treated patients (dexmedetomidine patients, average seven days; lorazepam patients, average three days; P = 0.01). One partially controlled study showed no advantage of a benzodiazepine (alprazolam) compared with neuroleptics in treating agitation associated with delirium, and another partially controlled study showed decreased effectiveness of a benzodiazepine (lorazepam), and increased adverse effects, compared with neuroleptics (haloperidol, chlorpromazine) for the treatment of acute confusion.

Authors' conclusions: No adequately controlled trials could be found to support the use of benzodiazepines in the treatment of non-alcohol withdrawal related delirium among hospitalised patients, and at this time benzodiazepines cannot be recommended for the control of this condition. Because of the scarcity of trials with randomization of patients, placebo control, and adequate concealment of allocation of subjects, it is clear that further research is required to determine the role of benzodiazepines in the treatment of non-alcohol withdrawal related delirium.

PubMed Disclaimer

Conflict of interest statement

None known.

Update of

Comment in

  • Benzodiazepines for delirium.
    Norrie P. Norrie P. Int J Evid Based Healthc. 2010 Jun;8(2):103-4. Int J Evid Based Healthc. 2010. PMID: 21077399 No abstract available.

References

References to studies included in this review

Pandharipande 2007 {published data only}
    1. Pandharipande P, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine va lorazepam on acute brain dysfunction in mechanically ventilated patients. The MRNDSS randomized controlled trial. JAMA 2007;298:2644‐53. - PubMed

References to studies excluded from this review

Breitbart 1996 {published data only}
    1. Breitbart W, Marott R, Platt MM, et al. A double‐blind trial of haloperidol, chlopromazine and lorazepam in the treatment of delirium in hospitalized AIDS patients. American Journal of Psychiatry 1996;153:231‐7. - PubMed
Christensen 1998 {published data only}
    1. Christensen DB, Benfield WR. Alprazolam as an alternative to low‐dose haloperidol in older cognitively impaired nursing facility patients. Journal of the American Geriatrics Society 1008;46:620‐5. - PubMed

Additional references

Adams 1984
    1. Adams R. Neuropsychiatric evaluation and treatment of delirium in the critically ill cancer patient. Cancer Bulletin 1984;36:156‐60.
APA 1994
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Discorders. IV. American Psychiatric Publishing, Washington, DC, 1994.
Breitbart 1996
    1. Breitbart W, Marotta R, Platt M, Weisman H, Derevenco M, Grau C, Corbera K, Raymond S, Lund S, Jacobsen P. A double‐blind trial of haloperidol, chlorpromazine, and lorazepamn in the treatment of delirium in hospitalized AIDS patients. American Journal of Psychiatry 1996;153:231‐7. - PubMed
Chalmers 1983
    1. Chalmers TC, et al. Bias in treatment assignment in controlled trials. New England Journal of Medicine 1983;309:1358‐61. - PubMed
Conn 2001
    1. Conn DK, Lief S. Diagnosing and managing delirium in the elderly. Canadian Family Physician 2001;47:101‐8. - PMC - PubMed
Dotson 2008
    1. Dotson Bryan, Peeters Michael J. Sedation With Dexmedetomidine vs Lorazepam in Mechanically Ventilated Patients. JAMA: The Journal of the American Medical Association 2008;299(13):1540‐. [PUBMED: PMID: 18387927] - PubMed
Dubois 2001
    1. Dubois MJ, Bergeron N, Dumont N, Dial S, Skrobik Y. Delirium in an intensive care unit: a study of risk factor. Intensive Care Medicine 2001;27:1297‐304. - PubMed
Ely 2001
    1. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit. JAMA 2001;286:2703‐10. - PubMed
Ely 2003
    1. Ely EW, Truman B, Shintani A, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation‐Sedation Scale (RASS). JAMA 2003;289:2983‐91. - PubMed
Ely 2007
    1. Ely E Wesley MD MPH, Girard Timothy D MD, Shintani Ayumi K PhD MPH, Jackson James C PsyD, Gordon Sharon M PsyD, Thomason Jason W W MD, et al. Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients *. [Article]. Crit Care Med 2007;35(1):112‐7. [MEDLINE: ] - PubMed
Johnson 1990
    1. Johnson JC. Delirium in the elderly. Emergency Medicine Clinics of North America 1990;8:255‐65. - PubMed
Lin 2004
    1. Lin SM, Liu CY, Wang CH, et al. The impact of delirium on the survival of mechanically ventilated patients. Critical Care Medicine 2004;32:2254‐59. - PubMed
Luxenberg 1996
    1. Luxenberg J. Delirium in the elderly. In: Lonergan E editor(s). Handbook of Geriatrics. Appleton & Lange, Stamford, Conneticut, 1996.
Marcantonio 1994
    1. Marcantonio ER, Juarez G, Goldman L, et al. The relationship of postoperative delirium with psychoactive medications. JAMA 1994;272:1518‐‐22. - PubMed
Mayo‐Smith 1997
    1. Mayo‐Smith MF, for the Ameerican Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. Pharmacological treatment of alcohol withdrawal: a meta‐analysis and evidence‐based practice guidelines. JAMA 1997;278:144‐51. - PubMed
McCusker 2001
    1. McCusker J, Cole M, Dendukuri N, et al. Delirium in older medical inpatients. Marker for subsequent cognitive and functional status. Canadian Medical Association Journal 2001;165:575‐83. - PMC - PubMed
McCusker 2002
    1. McCusker J, Cole M, Abrahamowicz M, et al. Delirium predicts 12 month mortality. Archives of Internal Medicine 2002;162:457‐63. - PubMed
McCusker 2004
    1. McCusker J, Cole MG, Dendukuri N. Does delirium increase hospital stay?. Journal of the American Geriatrics Society 2004;51:1539‐46. - PubMed
Mulrow 1997
    1. Mulrow CD, Oxman AD. Cochrane Collaboration Handbook. Oxford Update Software, Oxford, UIK, 1997.
Pandharipande 2006
    1. Pandharipande P, Shintani A, Peterson J, et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006;104:21‐6. - PubMed
Pandharipande 2008
    1. Pandharipande Pratik P, Girard Timothy D, Ely E Wesley. Sedation With Dexmedetomidine vs Lorazepam in Mechanically Ventilated Patients‐‐Reply. JAMA: The Journal of the American Medical Association 2008;299(13):1542‐. - PubMed
Salzman 1986
    1. Salzman C, Green AI, Rodriguez‐Viall F, Jaskiw GI. Benzodiazepines combined with neuroleptics for management of severe disruptive behavior. Psychosomatics 1996;27:7‐22. - PubMed
Schulz 1994
    1. Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomization from the reports of controlled trials published in obstetrics and gynecology journals. JAMA 1994;272:125‐8. - PubMed
Sessler 2002
    1. Sessler CN, Gosnell M, Grap MJ, et al. The Richmond Agitation‐Sedation Scale: validity and reliability in adult intensive care patients. American Journal of Respiratory and Critical Care Medicine 2002;166:1388‐44. - PubMed
Sumner 1994
    1. Sumner AD, Simons RJ. Delirium in the hospitalized elderly. Cleveland Clinic Journal of Medicine 1994;61:258‐62. - PubMed
Trzepacz 1988
    1. Trzpacz PT, Baker RW, Greenhouse J. A symptom rating scale for delirium. Psychiatry Research 1988;23:89‐97. - PubMed
Tune 2002
    1. Tune L. The role of antipsychotics in treating delirium. Current Psychiatry Reports 2002;4:209‐12. - PubMed
WHO 1993
    1. The World Health Organization. The ICD‐10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research. World Health Organization, Geneva, Switzerland, 1993.

Publication types

MeSH terms